The intercellular adhesion of circulating leukocytes to vascular endothelium is a prerequisite for leukocyte emigration from the blood to extravascular tissues. This process is facilitated by adhesion molecules on the surfaces of both the vascular endothelial cells and the leukocytes. The experiments presented here demonstrate for the first time that the leukocyte adhesion receptor, intercellular adhesion molecule-1, is constitutively expressed on cultured cerebromicrovascular endothelial cell lines derived from both spontaneously hypertensive (SHR) rats and normotensive Wistar-Kyoto (WKY) rats. Both cultures contained similar numbers of cells constitutively expressing this adhesion molecule (31.4% and 29.6%, respectively). Adhesion molecule expression was up-regulated by interleukin-1 p, tumor necrosis factor-a, inter-
feron-y and lipopolysaccharide in a dose-and time-dependent manner. Both cultures exhibited similar maximum levels of adhesion molecule up-regulation to optimal concentrations of all three cytokines. However, SHR endothelial cells were more sensitive to all three cytokines; significantly higher levels of intercellular adhesion molecule-1 expression were seen on SHR as opposed to WKY endothelial cells cultured with sub-optimal cytokine concentrations. It was also observed that lipopolysaccharide up-regulated intercellular adhesion molecule-1 expression on SHR endothelial cells to a greater extent than on WKY endothelial cells.
The findings that intercellular adhesion molecule-1 can be up-regulated to a greater degree on SHR endothelial cells may have important implications for in vivo perivascular leukocyte accumulation under hypertensive conditions. These observations indicate a possible mechanism by which hypertension may predispose to the development of disorders such as atherosclerosis and stroke. [ etc.) which interact with their complementary ligands (membrane-associated glycoproteins [integrins]) present on leukocytes (e.g., LFA-1, VLA-4, etc.). Although essential for host repair and defense, intercellular adhesion processes may also result in endothelial injury which occurs during allograft rejection (4) and in chronic inflammatory disorders such as autoimmune murine lupus nephritis (5) and atherosclerosis (6). The expression of adhesion molecules by cerebromicrovascular EC, as well as the resultant adherence of leukocytes and their migration have also been studied in disease states, including hemorrhagic shock, cerebral ischemic stroke, atherosclerosis, and multiple sclerosis (7-12). These disorders are characterized, in part, by leukocyte adhesion to cerebromicrovascular EC and subsequent extravascular migration. The above studies have documented the expression of adhesion molecules on cerebromicrovascular EC and the resultant interactions with various circulating leukocytes.
In recent years, ICAM-1 (CD54) expression, in particular, has been demonstrated to promote adhesion of a variety of blood leukocytes including lymphocytes, neutrophils, and monocytes (1, 13-16). ICAM-1 is very strongly expressed by certain nonhematopoietic cells, such as vascular EC, and weakly expressed by some blood mononuclear cells, such as monocytes and lymphocytes (17) . ICAM-1 expression can be induced and/or up-regulated in vitro by a variety of cytokines such as interleukin-1 p (IL-1 p), tumor necrosis factor-a (TNFa), and interferon-y (IFNy) (2, 13, 16, 18) . In addition, lipopolysaccharide (LPS), a prototypic stimulus to activate the cytokine system, also enhances ICAM expression (19) .
In rats, in vitro ICAM-1 expression has been reported in EC isolated from heart (20) and peripheral lymph nodes (21, 22) . In the present study, cerebromicrovascular endothelial cell lines derived from spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) were examined for their ability to constitutively express ICAM-1. In addition, data are also presented demonstrating the regulation of ICAM-1 expression on SHR and WKY cerebromicrovascular EC by various cytokines and LPS. The comparison of ICAM-1 expression and regulation on both SHR and WKY cerebromicrovascular EC offers a unique opportunity to examine the possible influence of hypertension, a known stroke risk factor, on EC responsiveness to proinflammatory factors.
Materials and Methods
Rats. Female Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats obtained from Taconic Farms (Germantown, NY) at 9 to 14 weeks of age and Sprague Dawley (SD) rats obtained from Harlan Sprague Dawley, Inc. (Indianapolis, IN) were utilized to isolate cerebromicrovascular EC used in this study. All animal procedures were in accordance with guidelines put forth in the NIH Guide for the Care and Use of Laboratory Animals.
Cerebromicrovascular EC Cultures. The isolation and cultivation of cerebromicrovascular EC from SHR, WKY and SD rats was performed with some modification as previously described (23) . Propagated EC (1 x 104/100 pl/well) were passaged and grown to confluency on 1% gelatin-coated coverslips or 96-well flat bottom microtiter plates at 37°C in humidified atmosphere of 5% C02/air in M-199 medium (containing 25 mM Hepes buffer, Earle's salts and L-glutamine) with 20% heat-inactivated FCS, 90 pg/ml heparin, 100 pg/ml streptomycin, 100 U/ml penicillin G, and 0.25 pg/ml amphotericin B as fungizone (all from GIBCO, Long Island, NY) and 20 pg/ml endothelial cell growth supplement (Collaborative Research, Bedford, MA). EC were positively identified by both immunocytochemistry and fluorescence-activated cell sorter (FACS) analysis using EC-specific anti-Factor VIIIrelated antigen (Accurate Chemical and Scientific Corp., Westbury, NY) as previously described (24) . All cultures used in experiments described here were obtained from three separate lines and were used at 3rd-1 lth passage. Confluent EC cultures derived from SHR, WKY and SD cerebral microvessels routinely exhibited characteristic cobblestone appearances, and >95% of cells in both of these cultures stained positively for FVIII-related antigen. Prior to use in adhesion and ICAM-1 assays, cells were washed twice with Hank's Balanced Salt Solution (HBSS) followed by incubation in media alone or with indicated concentrations of recombinant IFNy (Genzyme Corp., Boston, MA), human IL-1p (Endogen, Boston, MA), recombinant human TNFa (Endogen), or LPS (Sigma, St. Louis, MO). All treatments were performed in quadruplicate wells. All reagents contained <10 pg/ml endotoxin as determined by E-toxate assay kit (Sigma).
CAM-1 Expression. EC cultures grown on gelatin-coated coverslips were extensively washed, prefixed in 1: 1 mixture glacial acetic acid and methanol (10 min, 4°C) and incubated at 37°C with 1:50 mouse monoclonal antibody (IgG,) to rat ICAM-1 (clone IA29; Seikagaku Corp., Rockville, MD) for 45 min. After incubation with 1 : 100 rhodamine-conjugated F(ab'),goat anti-mouse IgG (Accurate) for 8 hr, SHR, WKY, and SD EC cultures were observed to constitutively express ICAM-1 by indirect immunofluorescence microscopy.
The relative level of ICAM-1 expression by EC cultures was quantitated by ELISA essentially as previously described (25) . Briefly, EC (2 x lo4 cells/50 pl/well) cultures in 96-well microtiter plates were incubated in the absence or presence of various concentrations of IFNy, IL-lp, TNFa, or LPS for indicated time periods at 37°C in 5% C02. Nonspecific binding sites were blocked by addition of heat-aggregated rabbit IgG (Sigma) and EC cultures were sequentially incubated at 37°C for 1 hr in the presence of IA29 (1: 1000); biotinylated anti-mouse IgG (1: 1000); and 0.33 pg/ml avidin-horseradish peroxidase. All substances were obtained from Sigma and were added at 100 pl/well. Plates were washed three times with PBS containing 2% BSA between each of the above steps. The reaction was developed by adding phosphatecitrate buffer/O.004% 0-phenylenediamine, 0.012% H202 (25"C, 30 min) and stopped by adding 4 N HC1. The optical density (O.D.) was immediately read at 490 nm (reference 630 nm). Background values for each culture condition, obtained by incubation of EC with an irrelevant mouse antibody (RT1 .B) specific for rat Class I1 MHC antigen (MRC 0 x 6 ; Accurate) in lieu of IA29, were subtracted from test values. FACS Analysis. Analysis of cell populations by flow cytometry was performed on a FACS IV analyzer (Becton Dickinson FACS System, Mountain View, CA). Cerebromicrovascular cells from SHR and WKY SD rats were stained with anti-ICAM-1 or RT1.B followed by rhodamine-conjugated goat F(ab'),antimouse IgG (Accurate). The data are displayed as a histogram with the y axis representing cell number and the x axis representing fluorescence intensity (in channel units). The mean fluorescence intensity (MFI) represents semiquantitative data on the mean number of fluorescent reagent-binding molecules expressed by the cells.
Results
Confluent EC cultures derived from SHR, WKY, and SD cerebral microvessels routinely exhibited characteristic cobblestone appearances, stained positively for FVIII-related antigen and ICAM-1. The expression of ICAM-1 by SHR and WKY cerebromicrovascular EC cultures was examined by FACS analysis. A similar percentage of cells in both EC cultures constitutively expressed ICAM-1 (Table I) both the percentage of positive cells and MFI values) were greater than WKY EC. No staining was observed with an irrelevant antibody (MRC 0x6) specific for rat Class I1 antigens.
The overall level of ICAM-1 expression by EC cultures was quantitated by ELISA. The capacity of TNFa to up-regulate ICAM-1 expression on both SHR and WKY EC was dose dependent (Fig. 1 ). Treatment with low concentrations of TNFa (i.e., 1-50 U/ml) enhanced ICAM-1 expression on SHR EC to a significantly greater extent (P < 0.01) than on WKY EC. No significant differences in the level of ICAM-1 expression were observed between SHR and WKY EC incubated in the presence of 100 or 200 U/ml of TNFa.
Experiments performed on other cerebrovascular EC cell lines derived from SHR, WKY and also from SD rats resulted in similar findings to those shown in Figure 1 and also demonstrate "normal" responsiveness of SD EC. In addition, other proinflammatory cytokines such as IFNy and IL-lp also increased ICAM-1 expression on these cells (Table 11) than on either WKY or SD EC; no significant differences in ICAM-1 expression were observed between WKY and SD EC.
The length of time required for ICAM-1 upregulation by TNFa, IL-lp, and IFNy treatment was examined. Treatment with IL-1 p increased ICAM-1 expression as early as 4 hr after addition to culture and reached a maximum after 16-24-hr culture (Fig. 2) . A slower effect on ICAM-1 expression was observed using TNFa and IFNy; very little increases in ICAM-1 expression were seen at 4 hr, but these cells also exhibited maximum levels of ICAM-1 expression after 24-hr culture. Culturing these cells with cytokines for greater than 24 hr did not significantly increase ICAM-1 expression. No differences were observed between SHR and WKY EC.
The ability of LPS to affect ICAM-1 expression was also examined. LPS dose-dependently enhanced ICAM-1 expression on SHR, WKY, and SD EC (Fig.  3) . The responsiveness of SHR EC to LPS-induced up-regulation of ICAM-1 was greater than WKY or ED EC. This enhanced responsiveness of SHR EC to LPS was observed at all LPS concentrations (0.1-100 pg/ml). Unlike the results obtained with cytokines, SHR EC responded to a significantly greater degree than either WKY or SD EC to optimal LPS concentrations (i.e., 100 pg/ml) in three of four experiments. Incubation of SHR, WKY, and SD EC cultures with > 100 pg/ml LPS did not significantly increase ICAM-1 expression. In fact, incubation with LPS concentrations of 300 pg/ml or higher resulted in lower levels of 
Discussion
The experiments here demonstrate the expression of the adhesion molecule, ICAM-1, on cultures of EC isolated from SHR, WKY, and SD rat brain microvessels. Although ICAM-1 expression by brain EC has been previously reported, this is the first demonstration in rats (10, 11, (26) (27) (28) . This implicates rat cerebromicrovascular EC in interactions with cells expressing CD1 l a or CD1 lb integrins (i.e., lymphocytes, monocytes, and neutrophils) (1, 13-16). Interactions between these various cell types and EC and the possible role of ICAM-1 in these adhesive interactions has been described in various disorders including rheumatoid arthritis, autoimmune murine lupus nephritis, experimental autoimmune encephalomyelitis (EAE), multiple sclerosis (MS), and atherosclerosis, and in ischemia-reperfusion injury models (5, 7-12, [26] [27] [28] .
The possible role of TNFa, IL-lp, and IFNy in pathogenic processes has been suggested in a number of disorders including EAE, MS, rheumatoid arthritis, and atherosclerosis (1 1, [29] [30] [31] [32] . The capacity of these cytokines to enhance ICAM-1 expression is well documented (2, 16, 18) and implicates ICAM-1 or possibly other adhesion molecules in the pathogenesis of these disorders. This may account for why cytokines are often referred to as "double-edged swords" and why mechanisms to inhibit synthesis or actions of cytokines are being explored in order to achieve therapeutic benefits (see review 33) .
In all experiments using suboptimal concentrations of cytokines or LPS, the level of up-regulated ICAM-1 expression was greater for SHR EC than for WKY or SD EC. Although the quantitative responses of various EC cultures differed, it was consistently observed that the relative degree of ICAM-1 upregulation by TNFa > IL-lP > IFNy. The maximum levels of ICAM-1 expression by SHR, WKY, and SD EC cultures were similar in cultures incubated with optimal concentrations of these cytokines. These data indicate possible differences in the sensitivity of these various EC cultures to cytokine treatment. The observation that optimal, as well as suboptimal, concentrations of LPS up-regulated ICAM-1 expression on SHR EC to a greater extent than on either WKY or SD EC indicates a possible difference in the mechanism($ by which these EC respond to LPS as opposed to cytokines. Such differences may be influenced by the number of LPS binding sites and possibly the affinity of these sites. The functional significance of the observations described here is indicated by preliminary experiments showing similar findings regarding enhanced adhesion of monocytes. The increased adhesion of monocytes to either LPS-or TNFa-and IL-1 @treated SHR EC was significantly higher than in WKY EC (P < 0.001).
The comparison of expression of adhesion receptors by cerebromicrovascular EC from normotensive (WKY and SD) and spontaneously hypertensive (SHR) rats provides a unique opportunity to examine the contribution of hypertension to immune responsiveness, or vice versa. There is already considerable evidence for a relationship between these parameters (34) . Although differences between the in vitro responsiveness of the SHR EC and WKY or SD EC cultures were observed only at suboptimal concentrations of cytokines, more differences could exist in vivo, where endothelium is subjected to blood flowkhear stress, factors related to hypertension and various agents including cytokines which may be rapidly washed away. Such in vivo differences are indicated by observations that LPS induces greater increases in plasma levels of TNFa in SHR than in WKY rats (35) . Additional studies regarding the influence of hypertension, as well as other potential risk factors for stroke, on expression of adhesion molecules by endothelium may provide insight toward defining a mechanism by which these factors contribute to the initiation of vascular injury.
